Bone Marrow Transplant Clinical Trial
Official title:
An Online Wellness Intervention for Bone Marrow Transplant Survivors
Specific aim #1: Assess feasibility (i.e., acceptability, practicality, demand, limited efficacy) of a home-based, online yoga intervention in patients following allogeneic stem cell transplant. Feasibility benchmarks will include: >70% satisfied with the intervention and >70% intending to continue participating in online yoga (i.e., acceptability); >70% of participants achieving an average of >42 min/week (70% of presceibed 60 min/week) of online yoga throughout the 12-week intervention (i.e., demand); >70% completing questionnaires across all four time points (i.e., practicality); at least small effect sizes of the intervention on physical function, fatigue, anxiety, sleep disturbance, social functioning, pain interference, depression, and quality of life as compared to a podcast control group (i.e., limited efficacy).
Online Yoga Group: The intervention will be 12-weeks in duration and will consist of a series
of pre-approved online yoga classes (6 manufactured specifically for the cancer-afflicted
patients instructed by Udaya yoga therapist, Jules Mitchell, MS). Patients will be asked to
complete a minimum of 60 minutes per week of yoga practice with encouragement to do more if
they can. All Udaya.com videos will include a proper warm-up, cool down, and closing
mindfulness activity (i.e., message from yoga therapist, brief meditation, final relaxation).
Qualified Udaya yoga instructors who collectively have over 200 years of training and
experience will expertly instruct the online yoga classes. Participants will be instructed to
view a safety handout (see yoga safety & modifications handout) before gaining access to the
Udaya video library. Yoga therapist, Jules Mitchell and PIs Huberty and Palmer will
pre-approve Udaya videos that are appropriate for this population.
A 12-week yoga prescription utilized in previous online yoga studies in MPN patients will be
used in the proposed study for BMT patients. The 12-week yoga prescription was designed to be
safe and progressive for cancer patients. During the intervention, all classes will offer
alternative poses, modifications, and use of props (i.e., yoga blocks and straps) in the
instance poses are difficult for the participant (i.e., painful, irregular, uneven breath)
and to ensure safety. In addition to specific instruction regarding form and safety, the yoga
therapist will provide descriptions of each video that includes tips and modifications to
poses (e.g., set the knee on your yoga mat if this feels more comfortable for you).
Additionally, patients will also receive a yoga modifications handout outlining the
contraindicated yoga poses with modifications (see yoga safety & modifications handout). This
handout will include an exercise warning for patients that experience dizziness,
lightheadedness or faintness, excessive shortness of breath, chest pain, and that they need
to stop the activity and contact their health care professional immediately if these symptoms
are experienced.
The participants will access their yoga prescription on the Udaya.com website using their
provided username and password (see instruction document). Participants will be asked to
participate in a total of at least 60 minutes of yoga and keep a log of their participation
utilizing a daily log available through a REDCap link (see yoga group weekly log). For the
entire study, participants will record in their log each time they participate in yoga, the
class in which they participated, how long they practiced (start and stop time), their
perceived exertion, and their perceived mindfulness. Research staff will provide a weekly
reminder email at the beginning of each week encouraging participation in their weekly yoga
(see weekly reminder emails). We will ask that participants follow the yoga prescription, but
if participants feel they want to deviate from the prescription they have the option to
participate in any videos assigned in previous weeks or in any of the additional videos
included each week in the prescription.
Podcast Control Group: The podcast control group will be asked to view 60 minutes per week of
online podcast videos. The podcast videos will contain general cancer-related health
education material. To match the online yoga group for time and attention, 60 minutes per
week will be prescribed, however, participants will have the ability to view additional
videos each week. Furthermore, participants will also track their podcast video viewing each
week in a daily log (see podcast group weekly log) by recording each time they view a video,
the video that they viewed, and how long they viewed the video.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02451462 -
Pilot Trial of Zoledronic Acid to Prevent Bone Loss in Hematopoietic Cell Transplant Recipients
|
N/A | |
Completed |
NCT03654599 -
Effects of Digital Stories Intervention on Psychosocial Well-being
|
N/A | |
Active, not recruiting |
NCT04395222 -
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
|
Phase 2 | |
Not yet recruiting |
NCT05603156 -
A Study of Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive
|
N/A | |
Completed |
NCT03530969 -
Geriatric Communication Skills Training Program for Oncology Clinicians
|
N/A | |
Recruiting |
NCT04115241 -
Activity Levels in Bone Marrow Transplant Patients
|
||
Completed |
NCT00143780 -
Pneumonia Vaccine in Bone Marrow Transplant Recipients: Usefulness of Donor Vaccination
|
Phase 4 | |
Completed |
NCT05662631 -
Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients
|
N/A | |
Completed |
NCT03028961 -
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT02575079 -
Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT
|
N/A | |
Active, not recruiting |
NCT02665065 -
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
|
Phase 3 | |
Completed |
NCT01735565 -
Neutrophil Extracellular Trap Formation in Patients Undergoing Bone Marrow Transplant
|
N/A | |
Completed |
NCT04041219 -
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
|
Phase 4 | |
Not yet recruiting |
NCT06361173 -
Spanish BMT4me Usability & Acceptability
|
||
Completed |
NCT03030248 -
Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients
|
Phase 2 | |
Completed |
NCT00695123 -
Screening for Subjects to Participate in Studies of Blood Disorders
|
||
Terminated |
NCT02057289 -
A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
|
Phase 1 | |
Completed |
NCT04275830 -
The Effects of Heart Rate Variability Biofeedback Training on Hematopoietic Cell Transplantation Patients
|
N/A | |
Completed |
NCT03245788 -
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
|
N/A | |
Completed |
NCT03758911 -
Perspectives on Bone Marrow Donors Who Donate for Their Parent
|